Skip to main content
Log in

Pertussis Resurgence in a Highly Vaccinated Population, Mazandaran, North of Iran 2008–2011: An Epidemiological Analysis

  • Original Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Objective

To describe the epidemiological characteristics of pertussis cases reported to Mazandaran Center for Diseases Control and Prevention (P-CDC) during the years 2008–2011 in Mazandaran, North of Iran.

Methods

The patients included were those who fulfilled the WHO definition for pertussis or those clinically diagnosed by physicians. The demographic features of cases, their vaccination status, the incidence rate per 100,000 population, the relative proportion of cases for each age group, and their relation to vaccination status of the patients were all determined.

Results

During the study period, a total of 518 cases of pertussis were reported; of which 43 were confirmed. The highest incidence rate and the largest proportion were 135.5 cases/100,000 and 37.7 %, respectively, observed in infants <12 mo of age. Almost 35.7 % of the cases were under vaccinated, however 54.4 % of them were fully vaccinated.

Conclusions

Pertussis infection has re-emerged in Mazandaran. It has caused a significant health problem in the susceptible young infants, and also among completely vaccinated children. Implementing strategies to protect these vulnerable infants and studies to evaluate the immunogenicity and efficacy of pertussis vaccine in Iran is recommended. It was difficult to confirm pertussis in the majority of cases, therefore, providing and improving laboratory diagnostic methods seems to be an urgent requirement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Cherry JD, Heininger U. Pertussis and other Bordetella infections. In: Feigin, Cherry, Demmeler, Harison, Kaplan, editors. Textbook of pediatric infectious diseases. 6th ed. USA: Elsevier Saunders; 2009. p. 1683–706.

    Google Scholar 

  2. Edwards KM, Decker MD. Pertussis vaccines. In: Plotkin, Orenstein, Offit, editors. Vaccines. 5th ed. USA: Elsevier Saunders; 2008. p. 467–517.

    Google Scholar 

  3. Cherry JD, Tan T, von König CH W, Forsyth KD, Thisyakorn U, Greenberg D, et al. Clinical definitions of pertussis: summary of a global pertussis initiative roundtable meeting, February 2011. Clin Infect Dis. 2012;54:1756–64.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Global Immunization Data. World Health Organization—UNICEF. Global immunization coverage in 2009: December 2010.

  5. Guris D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990–1996. Clin Infect Dis. 2000;6:348–57.

    Article  Google Scholar 

  6. Cortese MM, Baughman AL, Zhang R, Srivastava PU, Wallace GS. Pertussis hospitalizations among infants in the United States, 1993 to 2004. Pediatrics. 2008;121:484–92.

    Article  PubMed  Google Scholar 

  7. Rohani P, Drake JM. The decline and resurgence of pertussis in the US. Epidemics. 2011;3:183–8.

    Article  PubMed  Google Scholar 

  8. Celentano LP, Massari M, Paramatti D, Salmaso S. Tozzi AE; EUVAC-NET Group. Resurgence of pertussis in Europe. Pediatr Infect Dis J. 2005;24:761–5.

    Article  PubMed  Google Scholar 

  9. Global Advisory Group. Expanded programme on immunization. Wkly Epidemiol Rec. 1981;56:9–16.

    Google Scholar 

  10. Esteghamati MR, Mansour ghanei R. Guidelines for surveillance of pertussis (pamphelel). Tehran:centers for diseases control and prevention. Deputy of Health: Ministry of health and Medication Education 2009.

  11. Goya MM. Pertussis reemergence notification. Tehran, Center of Diseases Control and Prevention. Deputy of Health and Medical Education: No 24740:20, February 2007.

  12. Saffar MJ, Khalilian AR, Rafee AR, Parsaei MR, Imanikhani S, Shojaei J, et al. Bordetella pertussis IgG and IgA antibodies seroprevalence among 1–35 y-old population: The role of subclinical pertussis infection. Indian J Pediatr. 2012;79:353–7.

    Article  PubMed  Google Scholar 

  13. Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J. 2005;24:S25–34.

    Article  PubMed  Google Scholar 

  14. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24:S58–61.

    Article  PubMed  Google Scholar 

  15. Cherry JD. Epidemiology of pertussis. Pediatr Infect Dis J. 2006;25:361–2.

    Article  PubMed  Google Scholar 

  16. Van Rie A, Wendelboe AM, Englund JA. Role of maternal pertussis antibodies in infants. Pediatr Infect Dis J. 2005;24:S62–5.

    Article  PubMed  Google Scholar 

  17. Healy CM, Rench MA, Edwards KM, Baker CJ. Pertussis serostatus among neonates born to Hispanic women. Clin Infect Dis. 2006;42:1439–42.

    Article  PubMed  Google Scholar 

  18. Gonik B, Puder KS, Gonik N, Kruger M. Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants. Infect Dis Obstet Gynecol. 2005;13:59–61.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Saffar MJ, Ajami A, Khalilian AR, Qaheri A, Saffar H. Pertussis seroimmunity among mother-infant pairs and infant immune response to pertussis vaccination. Indian Pediatr. 2007;44:916–8.

    CAS  PubMed  Google Scholar 

  20. Westra TA, de Vries R, Tamminga JJ, Sauboin CJ, Postma MJ. Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands. Clin Ther. 2010;32:1479–95.

    Article  PubMed  Google Scholar 

  21. McIntyre P, Wood N. Pertussis in early infancy: disease burden and preventive strategies. Curr Opin Infect Dis. 2009;22:215–23.

    Article  PubMed  Google Scholar 

  22. Forsyth KD, von Konig CH W, Tan T, Caro J, Plotkin S. Prevention of pertussis: recommendations derived from the second global pertussis initiative roundtable meeting. Vaccine. 2007;30(25):2634–42.

    Article  Google Scholar 

  23. Munozf, England J. Infact pertussis: is cocooning the answer. Clin Infect Dis. 2011;53:885–92.

    Article  Google Scholar 

  24. Mohammed-Jafar S, Abolghasem A, Narges M, Hiva S, Ali-Reza K. Prepregnancy pertussis immunization: effect on materno-neonatal antibody titers and infant immune response to whole-cell pertussis vaccination. J Vaccine. 2012;3:7. doi:10.4172/2157-7560.1000157.

  25. Mooi FR, de Greeff SC. The case for maternal vaccination against pertussis. Lancet Infect Dis. 2007;7:614–24.

    Article  PubMed  Google Scholar 

  26. Wood N, Siegrist CA. Neonatal immunization: where do we stand? Curr Opin Infect Dis. 2011;24:190–5.

    Article  PubMed  Google Scholar 

  27. Strebel PM, Cochi SL, Farizo KM, Payne BJ, Hanauer SD, Baughman AL. Pertussis in Missouri: evaluation of nasopharyngeal culture, direct fluorescent antibody testing, and clinical case definitions in the diagnosis of pertussis. Clin Infect Dis. 1993;16:276–85.

    Article  CAS  PubMed  Google Scholar 

  28. Schmidt-Schläpfer G, Liese JG, Porter F, Stojanov S, Just M, Belohradsky BH. Polymerase chain reaction (PCR) compared with conventional identification in culture for detection of Bordetella pertussis in 7153 children. Clin Microbiol Infect. 1997;3:462–7.

    Article  PubMed  Google Scholar 

  29. Heininger U, Schmidt-Schläpfer G, Cherry JD, Stehr K. Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics. 2000;105:E31.

    Article  CAS  PubMed  Google Scholar 

Download references

Contributions

MJS: Chief executive designer of the study and wrote the manuscript; GG and AH: Implementation of the study and collection of medical records; MSR: Designing of the study, analyzing the data, drafting the manuscript and will act as guarantor for this paper.

Conflict of Interest

None.

Role of Funding Source

This project was funded by the Vice Chancellor for Research, Mazandaran University Medical Sciences, Iran.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohammad Sadegh Rezai.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saffar, M.J., Ghorbani, G., Hashemi, A. et al. Pertussis Resurgence in a Highly Vaccinated Population, Mazandaran, North of Iran 2008–2011: An Epidemiological Analysis. Indian J Pediatr 81, 1332–1336 (2014). https://doi.org/10.1007/s12098-014-1445-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-014-1445-0

Keywords

Navigation